Genetic Disorder News and Research

RSS
Hemaquest Pharmaceuticals' HQK-1001 holds promise for sickle cell disease and beta thalassemia

Hemaquest Pharmaceuticals' HQK-1001 holds promise for sickle cell disease and beta thalassemia

Cedars-Sinai Regenerative Medicine Institute supplies stem cells to aid Huntington's disease research

Cedars-Sinai Regenerative Medicine Institute supplies stem cells to aid Huntington's disease research

RCT licensee Dyax receives approval from the FDA for KALBITOR

RCT licensee Dyax receives approval from the FDA for KALBITOR

New approach to protein misfolding may lead to novel therapies for a number of diseases

New approach to protein misfolding may lead to novel therapies for a number of diseases

New study reveals genetic alteration can lead to severe childhood obesity

New study reveals genetic alteration can lead to severe childhood obesity

Licensing agreement to develop and commercialize potential treatment for Gaucher’s disease signed

Licensing agreement to develop and commercialize potential treatment for Gaucher’s disease signed

New step in the proofreading process that helps maintain accuracy of DNA replication identified

New step in the proofreading process that helps maintain accuracy of DNA replication identified

Santaris Pharma's LNA technology based microRNA-targeted therapy holds promise for HCV

Santaris Pharma's LNA technology based microRNA-targeted therapy holds promise for HCV

ISIS-FXIRx and ISIS-SMNRx included in Isis Pharmaceuticals' development pipeline

ISIS-FXIRx and ISIS-SMNRx included in Isis Pharmaceuticals' development pipeline

NHLBI awards stimulus funds for hemophilia drug research

NHLBI awards stimulus funds for hemophilia drug research

FDA grants approval for Dyax' KALBITOR for treating HAE patients

FDA grants approval for Dyax' KALBITOR for treating HAE patients

Copper sequestering drug tetrathiomolybdate shown to be effective in treating Wilson disease

Copper sequestering drug tetrathiomolybdate shown to be effective in treating Wilson disease

FDA approves Berinert for treating HAE in adults and adolescents

FDA approves Berinert for treating HAE in adults and adolescents

CVS/pharmacy and Warner Home Video team up to raise critical funds for cystic fibrosis

CVS/pharmacy and Warner Home Video team up to raise critical funds for cystic fibrosis

Worldwide collaboration leads to treatment for rare skin disorder

Worldwide collaboration leads to treatment for rare skin disorder

New initiative launched to take care of patients with sickle cell disease

New initiative launched to take care of patients with sickle cell disease

Amniotic fluid stem cells have potential to become specialized cell types, say researchers

Amniotic fluid stem cells have potential to become specialized cell types, say researchers

EraGen Biosciences to have access to Illumina’s BeadXpress platform

EraGen Biosciences to have access to Illumina’s BeadXpress platform

Scientists use exome sequencing method to discover the cause of mendelian disorder

Scientists use exome sequencing method to discover the cause of mendelian disorder

I-STEM team succeeds in recreating a whole epidermis from hES cells

I-STEM team succeeds in recreating a whole epidermis from hES cells

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.